Collaboration Agreements (Tables)

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule Of Collaboration Revenue

Revenue was as follows for the years ended December 31, 2022, 2021 and 2020:

	Year Ended December 31,
	2022		2021		2020
Neurocrine Biosciences:
Recognition of the transaction price	$	372	$	3,715	$	26,810
Research and development services		1,938		6,452		5,356
Milestone payments		7,124		5,270		—
Pacira BioSciences:
Milestone payments		—		3,000		—
Total revenue	$	9,434	$	18,437	$	32,166